Patent 9504756 was granted and assigned to Seagen on November, 2016 by the United States Patent and Trademark Office.
The present invention provides Ligand-Drug Conjugates, Drug-Linkers, Linkers, and Ligand-Linker Conjugates comprising a self-stabilizing linker assembly component.